If Safety Data Open Door In US, Cannabinoids’ Lawful Use In Supplements At Least A Year Off

At FDLI annual meeting, attorneys cast doubt on CBD rules outlook. Paul Joseph says regulations are at least a year away while Jonathan Havens doubts FDA is even working on regulations, including GMPs, because it is still asking industry for specific safety details.

Marijuana Pot Weed Cannabis United States America USA Map 3d Illustration

Food and drug attorneys law doubt the US Food and Drug Administration soon will offer a regulatory pathway for using cannabidiol and other cannabinoids in dietary supplements or other non-drug products.

During an 8 October session at the Food and Drug Law Institute annual conference, Paul Joseph of Foley & Lardner...